Yalong Xie

Evaluation of hepatic steatosis before liver transplantation in ex vivo by volumetric quantitative PDFF‐MRI

I. Kamel, D. Hu, Zhen Li, 2020, Magnetic resonance in medicine.

Combination of lymphocyte number and function in evaluating host immunity

M. Huang, H. Hou, Ziyong Sun, 2019, Aging.

TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.

Liang Zhou, P. Zhou, D. Du, 2020, International immunopharmacology.

The Novel MyD88 Inhibitor TJ-M2010-5 Protects Against Hepatic Ischemia-reperfusion Injury by Suppressing Pyroptosis in Mice

P. Zhou, D. Du, Yang Yang, 2022, Transplantation.

Daidzein ameliorated concanavalin A-induced liver injury through the Akt/GSK-3β/Nrf2 pathway in mice

Xiaofan Hu, P. Xiong, Bo Yang, 2021, Annals of translational medicine.

TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway

D. Du, Zhimiao Zou, Zeyang Li, 2022, Frontiers in Pharmacology.

The role of pyroptosis in hepatocellular carcinoma

Yang Yang, Zhimiao Zou, Zeyang Li, 2023, Cellular Oncology.

Robust and Efficient Covert Channel Communications in Operating Systems: Design, Implementation and Evaluation

Yongji Wang, Liping Ding, JingZheng Wu, 2013, 2013 IEEE Seventh International Conference on Software Security and Reliability Companion.

TJ-M2010-5, A self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-κB pathway.

Liang Zhou, P. Zhou, D. Du, 2022, Chemico-biological interactions.